|
H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, trend analysis, applicable previous investigation(s), sample (if available), and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of infusion set leakage at the claves was confirmed and the cause appeared to be use-related.The product returned for evaluation was one 22ga x 0.75¿ miniloc safety infusion set with y-site.Light usage residues were observed and the safety mechanism was engaged.Non-vad needleless injection caps were attached to both luer adapters.An attempt to infuse water through the sample using a 12ml syringe revealed the sample to be patent to infusion and aspiration; however, during pressurization, spraying leaks were observed emanating from the septa of both injection caps.Microscopic inspection of the injection caps revealed splits in both septa.The splits were of a size and shape consistent with hypodermic needle tips.It appeared that needles had been used to access both needleless injection caps, rather than male luer-lock devices.That access resulted in damage to the injection caps which caused them to leak during device access.A lot history review (lhr) of reen2778 showed one other similar product complaint(s) from this lot number.The complaints for this lot number have been reported from the same facility.
|